COVID-19 ANTIGEN LATERAL FLOW TEST DEVICE - India CDSCO Medical Device Registration

COVID-19 ANTIGEN LATERAL FLOW TEST DEVICE is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000021_735657812cbaf9d60e8d0bf9fc576603_f5e90f83f8a74f66447ab752eeab0c6e. This device is marketed under the brand name PathoCatchTM. The license holder is Mylab Discovery S0lutions Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

COVID-19 ANTIGEN LATERAL FLOW TEST DEVICE

UID: MFG/IVD/2020/000021_735657812cbaf9d60e8d0bf9fc576603_f5e90f83f8a74f66447ab752eeab0c6e

Brand Name

PathoCatchTM

License Holder

Mylab Discovery S0lutions Pvt. Ltd

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

COVID-19 Antigen Lateral Flow Test Device is used as an aid for the detection of novel COVID-19 virus in nasal and throat swab specimens, as an aid in the diagnosis of infection with Corona Virus